ScholarWorks@Korea University: Seo, Yeon Seok

Detailed Information

Seo, Yeon Seok (서연석)

College of Medicine (Department of Medical Science)

Research Area

Tel 안6608
Homepage

ResearcherID ORCiD Scopus Google Scholar ID ResearchGate

Keyword

Hepatocellular carcinoma:9||hepatocellular carcinoma:9||Cirrhosis:8||chronic hepatitis B:7||liver cirrhosis:6||entecavir:6||Liver cirrhosis:6||transient elastography:4||Resistance:4||liver stiffness:4||Ascites:4||lamivudine:4||Prognosis:4||cirrhosis:4||Fibrosis:3||colonoscopy:3||antiviral therapy:3||Acute hepatitis:3||treatment:3||Entecavir:3||polyethylene glycol:3||hepatitis B:3||prognosis:3||Survival:3||hepatitis B virus:2||Computed tomography:2||Inflammation:2||Renal dysfunction:2||FibroScan:2||risk prediction:2||HBV:2||liver fibrosis:2||Chronic hepatitis:2||Liver fibrosis:2||Creatitine:2||Recurrence:2||Sorafenib:2||Hepatitis C:2||Endoscopy:2||Mortality:2||Endoscopic submucosal dissection:2||combination drug therapy:2||Acute hepatitis A:2||Gastric ulcer:2||necroinflammation:2||Cystatin C:2||adefovir:2||Lamivudine:2||ascorbic acid:2||platelet:2||safety:2||ammonia:2||Hepatitis B virus:2||Hepatitis A:2||Liver stiffness:2||insulin resistance:2||resistance:2||Chronic hepatitis B:2||Therapy:2||overestimation:2||Adefovir:2||cyanoacrylate:1||rebleeding:1||recurrence:1||heat shock protein:1||Psoas muscle:1||corticosteroid:1||Relapse:1||liverrelated mortality:1||Pegylated interferon:1||Liver diseases:1||Sodium picosulfate:1||Osteopontin:1||inactive carriers:1||liver endothelial cells (LEC):1||genotype:1||Rebamipide:1||Response:1||antiviral resistance:1||multicenter study:1||Caco2 cells:1||Fibrosis marker:1||Colitis:1||proton pump inhibitor:1||omeprazole:1||괴사염증:1||Metabolic syndrome:1||Diagnosis:1||Barcelona Clinic Liver Cancer stage A:1||Pancreatic stellate cells:1||expanded indication:1||decompensation:1||NORMAL SALINE:1||STOMACH:1||cap assistance:1||Bowel preparation:1||Colonoscopy:1||Elastography:1||radioembolization:1||substaging:1||histoacryl:1||Guideline:1||chemotherapyinduced mucositis:1||chemotherapy:1||protective effect:1||cystatin C:1||Obturation:1||Barcelona Clinic Liver Cancer:1||Response evaluation criteria in solid tumors:1||Liver biopsy:1||Hepatitis B:1||Laparoscopic surgery:1||cytokine:1||Carcinoembryonic antigen:1||Sustained virological response:1||Liver transplantation program:1||Sedative endoscopy:1||hepatocyte:1||mortality:1||Polaprezinc:1||Carnosine:1||Severity:1||Rebleeding:1||Fentanyl patch:1||staging system:1||gastroscopes:1||간섬유화:1||Biomarkers:1||Natural killer cell:1||Interferongamma:1||Risk of Death:1||polyurethane:1||upper esophageal sphincter:1||Inter:1||Autoimmune:1||stiffness:1||Liver Cirrhosis:1||Tenofovir:1||Comparison:1||dibutyltin dichloride:1||bowel preparation:1||Biopsy, fineneedle:1||creatinine:1||Ligation:1||Shear wave:1||Hepatitis B core antigens:1||Hepatitis B surface antigens:1||Histologic activity index:1||glutaminase:1||Serum MicroRNA:1||Clevudine:1||Transmission:1||chronic kidney disease:1||Hepatitis B surface antigen:1||nitric oxide:1||Fibroscan:1||Transient elastography:1||Patency:1||Chronic hepatitis C:1||Interferon:1||HBeAgnegative chronic hepatitis B:1||Anxiety:1||HMGB1:1||autoimmune hepatitis:1||Pain:1||Hyaluronic acid:1||Decision tree algorithm:1||Intestinal Polyposis:1||Peritonitis:1||varicose veins:1||Hemostasis:1||Stage:1||risk prediction score:1||oral antiviral agent:1||Sequential therapy:1||sharp foreign body:1||Mantle cell lymphoma:1||Complication:1||aminotransferase:1||metabolic syndrome:1||terlipressin:1||Chronic Liver Disease:1||Yttrium90:1||stage:1||quality:1||Endosonography:1||Portal hypertension:1||Obliteration:1||Carcinoma:1||hepatocellular:1||Cyanoacrylate:1||Malignant gastroduodenal obstruction:1||Prothrombin induced by vitamin K deficiency or antagonist II:1||Donor selection:1||colon bowel preparation:1||cyclooxygenase2 inhibitor:1||Liver injury:1||Pancreatic neoplasms:1||Diverticulitis:1||Transarterial chemoembolization:1||Gallbladder:1||diagnostic criteria:1||clevudine:1||Skin Manifestations:1||Liver malignancy:1||osteoclast:1||osteoblast:1||5Fluorouracil:1||prevention and control:1||peroxisome proliferatoractivated receptors:1||tumor necrosis factor:1||간 강성도:1||covered stent:1||physical property:1||gastric acid:1||hepatitis Brelated liver cirrhosis:1||Duodenal ulcer:1||HMGCoA reductase inhibitor:1||endoscopic submucosal dissection:1||DUODENAL HEMATOMA:1||Esophagus:1||Cleansing score system:1||Oil:1||Trainee:1||hyponatremia:1||haptoglobin:1||radiotherapy:1||5fluorouracil:1||ursodeoxycholic acid:1||pentoxifylline:1||Band ligation:1||ulcer:1||Liver transplantation:1||sodium picosulfate with magnesium citrate:1||Hepatic encephalopathy:1||Heat shock proteins:1||neuropsychological:1||heat shock proteins:1||postoperative mortality:1||prediction model:1||Radioembolization:1||Hepatic arterial infusion chemotherapy:1||Cisplatin:1||Hemorrhage:1||Milk fat globuleEGF factor8:1||tenofovir disoproxil fumarate:1||Synergism:1||Intercellular space:1||Clinical outcome:1||alanine aminotransferase:1||international normalized ratio:1||marker:1||treatment response:1||TARE:1||curative treatment:1||spleen:1||varices:1||gastric varices:1||Pancreas:1||Hong Kong Liver Cancer:1||Hepatitis B, chronic:1||Surgical smoke:1||Offtreatment:1||subclinical ascites:1||performance:1||Predictive factor:1||Dialysis:1||Renal insufficiency:1||precore variant:1||core promoter variants:1||highfiber diet:1||simvastatin:1||Glypican3:1||serum HBsAg levels:1||Propofol:1||Toxic:1||Zinc:1||diagnosis:1||Capsule Endoscopy:1||Melena:1||Bremsstrahlung:1||Y90:1||Low dose:1||Carcinoma, hepatocellular:1||bserver variation:1||expiration:1||inspiration:1||nonalcoholic fatty liver disease:1||survival:1||HCC:1||prophylaxis:1||Chronic pancreatitis:1||pancreatic fibrosis:1||Sarcopenia:1||Technique:1||hepatorenal syndrome:1||Neoplasm staging:1||genetic variations:1||Hepatocellular Carcinoma:1||Macrovascular Invasion:1||chronic:1||Varices:1||telbivudine:1||alcoholic:1||hepatitis B e antigen:1||Early gastric cancer:1||Endoscopic submucosal tunnel dissection:1||Morbidity:1||Herb:1||hepatic stellate cells (HSC):1||Gemcitabine:1||Quercetin:1||Cholestasis:1||encephalopathy:1||Procollagen III Nterminal peptide:1||DNA repair molecules:1||Alanine aminotransferase:1||High dose:1||intralesional injections:1||nonalcoholic fatty liver:1||급성 간염:1||Helicobacter pylori:1||Triple therapy:1||PPAR gamma agonist:1||autolysis:1||endoscopic removal:1||Gastroesophageal reflux disease:1||Warm water:1||Biological Markers:1||regular diet:1||renal dysfunction:1||severe alcoholic hepatitis:1||hepatic encephalopathy:1||benexate hydrochloride betadex:1||stomach:1||chronic liver disease:1||Stent:1||Polyethylene glycol with ascorbic acid:1||Outcome:1||serum HBV DNA levels:1||Depression:1||ethanol:1||morbidity:1||Hinchey classification:1||Gastric variceal bleeding:1||normogram:1||IgM antiHAV:1||Gastrointestinal Hemorrhage:1||Ulcerative:1||Pyoderma Gangrenosum:1||Microsphere:1||prognostic power:1||gastric cancer:1||electric impedance:1||Risk factor:1||silicone:1||Gastritis:1||SUBMUCOSAL INJECTION:1||Stomach:1||Primary:1||Solitary, Cyclin D1 positive:1||Transmission electron microscopy:1||Capsule endoscopy:1||seizure:1||varix:1||

STATISTICS: Total View :6,822,242; Today View :31,527

RSS_1.0 RSS_2.0 ATOM_1.0

145 Anam-ro, Seongbuk-gu, Seoul, 02841, Korea+82-2-3290-2963

Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.

Detailed Information

Keyword

BROWSE